Clinical Characteristics of Long-term Survivors of Metastatic HER2+Breast Cancer

被引：0
|
作者：
Goldbach, Macy [1 ]
Burkbauer, Laura [1 ]
Keele, Luke [1 ]
Nazarian, Susanna [1 ]
Rothman, Jami [1 ]
Tchou, Julia [1 ]
机构：
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
788275
引用
收藏
页码：S466 / S466
页数：1
相关论文
共 50 条
  • [1] Clinical and molecular analysis of long-term HER2 positive metastatic breast cancer survivors
    Omarini, C.
    Caprera, C.
    Manfredini, S.
    Caggia, F.
    Guaitoli, G.
    Filieri, M. E.
    Bettelli, S. R.
    Moscetti, L.
    Kaleci, S.
    Tamma, A. V.
    Cascinu, S.
    Piacentini, F.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [2] Factors associated with short- and long-term survival in metastatic HER2+breast cancer.
    Leone, Jose Pablo
    Leone, Julieta
    Vallejo, Carlos Teodoro
    Parsons, Heather Anne
    Hassett, Michael J.
    Lin, Nancy U.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Clinical and pathological characteristics of a representative cohort of long-term metastatic breast cancer (MBC) survivors
    Giesler, D. L.
    Rosenzweig, M. Q.
    Diergaarde, B.
    Puhalla, S. L.
    [J]. CANCER RESEARCH, 2017, 77
  • [4] Long-term survivor (LTS) characteristics in HER2+metastatic breast cancer (MBC)
    Yardley, Denise Aysel
    Tripathy, Debu
    Brufsky, Adam M.
    Rugo, Hope S.
    Kaufman, Peter Andrew
    Mayer, Musa
    Feng, Shibao
    Abidoye, Oyewale O.
    Yood, Marianne Ulcickas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [5] Metastatic pancreatic cancer Characteristics of long-term survivors
    Mandelson, M.
    Picozzi, V.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [6] Long-term outcomes after neoadjuvant trastuzumab and chemotherapy for HER2+breast cancer
    Gropper, A.
    Burstein, H. J.
    Harris, L.
    Anderson, K. S.
    Gold, J. M.
    Younger, W. J.
    Bunnell, C. A.
    Najita, J. S.
    Winer, E. P.
    Mayer, E. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Clinical predictors of long-term survival in HER2-positive metastatic breast cancer
    Murthy, Pooja
    Kidwell, Kelley M.
    Schott, Anne F.
    Merajver, Sofia D.
    Griggs, Jennifer J.
    Smerage, Jeffrey D.
    Van Poznak, Catherine H.
    Wicha, Max S.
    Hayes, Daniel F.
    Henry, N. Lynn
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (03) : 589 - 595
  • [8] Clinical predictors of long-term survival in HER2-positive metastatic breast cancer
    Pooja Murthy
    Kelley M. Kidwell
    Anne F. Schott
    Sofia D. Merajver
    Jennifer J. Griggs
    Jeffrey D. Smerage
    Catherine H. Van Poznak
    Max S. Wicha
    Daniel F. Hayes
    N. Lynn Henry
    [J]. Breast Cancer Research and Treatment, 2016, 155 : 589 - 595
  • [9] Clinical characteristics of long-term responders to anti-HER2 therapy in metastatic breast cancer: A review of the charactHER clinical data
    Skrobo, D.
    Walsh, N.
    Quinn, C.
    Walshe, J.
    Smyth, L. M.
    Gullo, G.
    Crown, J. P.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S78 - S78
  • [10] Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER
    Yardley, D. A.
    Tripathy, D.
    Brufsky, A. M.
    Rugo, H. S.
    Kaufman, P. A.
    Mayer, M.
    Magidson, J.
    Yoo, B.
    Quah, C.
    Yood, M. Ulcickas
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (11) : 2756 - 2764
12345